↑ 薬物リストへ　← 戻る

Ondansetron 8 mg film-coated tablets    (DrugBank: Ondansetron)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
6パーキンソン病1

6. パーキンソン病　［臨床試験数：2,123，薬物数：2,046（DrugBank：324），標的遺伝子数：183，標的パスウェイ数：198］
Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,123 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2019-003962-41-GB
(EUCTR)		23/03/202006/02/2020Trial of Ondansetron as a Parkinson's HAllucinations Treatment: TOP HATTrial of Ondansetron as a Parkinson’s HAllucinations Treatment - TOP HAT Adults aged over 18 years with Parkinson's disease and visual hallucinations
MedDRA version: 21.1;Level: LLT;Classification code 10047570;Term: Visual hallucinations;System Organ Class: 100000004873;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]		Trade Name: Ondansetron 8 mg film-coated tablets
Product Name: Ondansetron 8 mg film-coated tablets
INN or Proposed INN: Ondansetron hydrochloride dihydrate		University College LondonNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		216Phase 2United Kingdom